Back to top

CAUT Bulletin Archives

September 2013


David Healy. Berkeley, CA: University of California Press, 2012; 320 pp; ISBN: 978-0-52027-098-5, cloth $41.95 usd; ISBN: 978-0-52027-576-8, paper $27.95 usd; ISBN: 978-0-52095-181-5, eBook $27.95 USD.

In this searing indictment David Healy tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. He further explains why these trends have basically ended the possibility of universal health care in the US and elsewhere around the world, and ends with suggestions for reform of our currently corrupted evidence-based medical system.

Quick Picks produced from information supplied by publishers.